Qun Li

Associate Process Development Scientist at Cellerant Therapeutics - San Carlos, California, United States

Qun Li's Contact Details
HQ
Location
San Carlos,California,United States
Company
Cellerant Therapeutics
Qun Li's Company Details
Cellerant Therapeutics logo, Cellerant Therapeutics contact details

Cellerant Therapeutics

San Carlos, California, United States • 5 Employees
Research

Cellerant Therapeutics is a clinical-stage company developing innovative cell- and antibody-based immunotherapies for hematologic malignancies and other blood-related disorders. Cellerant's romyelocel-L is a universal cell therapy which does not require HLA matching intended to prevent bacterial and fungal infections during neutropenia. In a randomized, controlled Phase 2 clinical trial in AML patients, romyelocel-L reduced infections and days in hospital. Cellerant is developing two novel antibody drug-conjugate (ADC) products: CLT030 to treat AML by selectively targeting and killing leukemic stem and blast cells, and CSC012-ADC for hematologic malignancies and solid tumor indications.

Details about Cellerant Therapeutics
Frequently Asked Questions about Qun Li
Qun Li currently works for Cellerant Therapeutics.
Qun Li's role at Cellerant Therapeutics is Associate Process Development Scientist.
Qun Li's email address is ***@cellerant.com. To view Qun Li's full email address, please signup to ConnectPlex.
Qun Li works in the Research industry.
Qun Li's colleagues at Cellerant Therapeutics are Joan Hughes, Rod Syoc, Julie Christensen, Trang Nguyen, Luqman Gbenro, Myralee Martinez, Helen Gebremicael and others.
Qun Li's phone number is
See more information about Qun Li